chr17-43852956-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_145273.4(CD300LG):​c.424G>C​(p.Ala142Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

CD300LG
NM_145273.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.346

Publications

0 publications found
Variant links:
Genes affected
CD300LG (HGNC:30455): (CD300 molecule like family member g) Members of the CD300 (see MIM 606786)-like (CD300L) family, such as CD300LG, are widely expressed on hematopoietic cells. All CD300L proteins are type I cell surface glycoproteins that contain a single immunoglobulin (Ig) V-like domain (Takatsu et al., 2006 [PubMed 16876123]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06452584).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD300LGNM_145273.4 linkc.424G>C p.Ala142Pro missense_variant Exon 3 of 7 ENST00000317310.5 NP_660316.2 Q6UXG3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD300LGENST00000317310.5 linkc.424G>C p.Ala142Pro missense_variant Exon 3 of 7 1 NM_145273.4 ENSP00000321005.3 Q6UXG3-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 11, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.424G>C (p.A142P) alteration is located in exon 3 (coding exon 3) of the CD300LG gene. This alteration results from a G to C substitution at nucleotide position 424, causing the alanine (A) at amino acid position 142 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
1.4
DANN
Benign
0.97
DEOGEN2
Benign
0.019
.;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.47
T;T
M_CAP
Benign
0.0033
T
MetaRNN
Benign
0.065
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.81
L;L
PhyloP100
-0.35
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.53
N;N
REVEL
Benign
0.012
Sift
Uncertain
0.019
D;D
Sift4G
Benign
0.11
T;T
Polyphen
0.020
.;B
Vest4
0.11
MutPred
0.47
Gain of glycosylation at A142 (P = 0.0359);Gain of glycosylation at A142 (P = 0.0359);
MVP
0.081
MPC
0.051
ClinPred
0.041
T
GERP RS
-0.51
Varity_R
0.089
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr17-41930324; API